Shenzhen Watmind Medical Co., Ltd – Trademark Portfolio
Entity Type: 99
Shenzhen Watmind Medical Co., Ltd has 5 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 4 are successfully registered — a 100% registration rate, with 1 application currently pending. The portfolio includes marks such as HM and WATMIND. Filings span 3 Nice Classification classes, with the highest activity in Class 35 (Advertising & Business) and Class 10 (Medical Apparatus).
8th Floor, Building A,
No. 16-1, Jinhui Road, Jinsha Community,
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Watmind Medical Co., Ltd's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Shenzhen Watmind Medical Co., Ltd have?
Shenzhen Watmind Medical Co., Ltd has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending.
What trademark classes does Shenzhen Watmind Medical Co., Ltd file in?
Shenzhen Watmind Medical Co., Ltd files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are Shenzhen Watmind Medical Co., Ltd's most well-known trademarks?
Shenzhen Watmind Medical Co., Ltd's registered trademark portfolio includes well-known marks such as HM and WATMIND. These are among 4 currently registered trademarks in the portfolio.
What is Shenzhen Watmind Medical Co., Ltd's trademark registration success rate?
Shenzhen Watmind Medical Co., Ltd has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.